Difference in Host Immune response to Methicillin-Resistant and Methicillin Sensitive Staphylococcus aureus (MRSA and

Poonam Naik1,2, Joveeta Joseph1

  • 1Jhaveri Microbiology Centre, Brien Holden Eye Research Centre, L. V. Prasad Eye Institute, Hyderabad, Telangana, India.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) triggers a stronger immune response in retinal cells than methicillin-susceptible S. aureus (MSSA). This suggests MRSA may be a target for new immunomodulatory therapies for endophthalmitis.

Area of Science:

  • Ophthalmology
  • Immunology
  • Microbiology

Background:

  • Endophthalmitis is a serious eye inflammation often caused by Staphylococcus aureus.
  • Differentiating the immune response to methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) is crucial for effective treatment.

Purpose of the Study:

  • To investigate the differential immune responses of retinal pigment epithelium (RPE) and microglia cells to MSSA and MRSA strains in vitro.
  • To identify potential therapeutic targets for MRSA-induced endophthalmitis.

Main Methods:

  • RPE and microglia cells (CHME-3) were exposed to MRSA and MSSA.
  • Expression of inflammatory mediators was analyzed using real-time quantitative PCR, ELISA, and immunofluorescence.
  • Heatmap and STRING analysis were employed to assess differential immune expression.

Main Results:

  • Both RPE and microglia cells expressed Toll-like receptors (TLRs) upon challenge with MRSA and MSSA, with varying expression levels.
  • MRSA infection led to higher expression of IL-1β, IL-8, IL-10, IL-6, and GM-CSF, and downregulation of TNF-α and IFN-γ compared to MSSA.
  • MRSA increased MMP-9 and MMP-2 activation in RPE cells, and MMP-9 in microglia.

Conclusions:

  • MRSA induces a more severe immune response in retinal cells than MSSA.
  • These findings highlight potential targets for immunomodulatory therapies in MRSA-related endophthalmitis.